Step 1 topics → General Pathology → Chronic Inflammation

Chronic Inflammation

USMLE Step 1 trap: Incorrectly assigns neutrophil dominance to chronic inflammation rather than macrophages and lymphocytes. Chronic inflammation is dominated by macrophages, lymphocytes, and plasma cells; neutrophils are the hallmark of acute inflammation and are not the primary cells in chronic inflammation.

Chronic inflammation is tested on USMLE Step 1 from three main angles: identifying the correct cell types, recognizing that it can start de novo without a prior acute phase, and understanding the downstream consequence of fibrosis. A major misconception is that chronic inflammation always follows unresolved acute inflammation — it doesn't; autoimmune diseases like rheumatoid arthritis and Hashimoto's thyroiditis begin with macrophage and lymphocyte infiltration from day one, skipping the neutrophilic acute phase entirely.

The exam will give you a clinical vignette describing a patient with a long-standing condition (rheumatoid arthritis, TB, sarcoidosis, Crohn's) and ask you to identify the predominant cells, predict the outcome, or explain why the process started without a classic acute phase. Application questions are more common than pure recall — expect to reason from histology descriptions or disease context rather than just memorize a list. USMLE Step 1 particularly likes to test whether you know that fibrosis is mediated by TGF-beta driving myofibroblast activation, not just vague 'scarring.'

The two biggest traps: confusing acute and chronic cellular players, and assuming chronic inflammation always follows unresolved acute inflammation. A student who only memorizes 'neutrophils = acute, macrophages = chronic' without understanding why chronic can start de novo will miss a significant subset of questions. Autoimmune diseases, low-virulence persistent infections, and prolonged toxic exposures all kick off chronic inflammation from the beginning — no prior neutrophil response required.

From real student decks
78%have cards covering this topic
62%have mature cards

Common misconceptions

Common mistake
Wrong: Neutrophils are the dominant cell type in chronic inflammation as they are in acute inflammation.
Right: Chronic inflammation is dominated by macrophages, lymphocytes, and plasma cells; neutrophils are the hallmark of acute inflammation and are not the primary cells in chronic inflammation.
Neutrophils are the first responders in acute inflammation because they extravasate rapidly in response to IL-8, C5a, and LTB4 — but they are short-lived and not suited for sustained responses. In chronic inflammation, the tissue is dominated by macrophages (which phagocytose debris and secrete cytokines like TNF, IL-1, and TGF-beta), lymphocytes (which drive adaptive immune responses), and plasma cells (which produce antibodies). If you see neutrophils called out in a chronic context on the exam, that's a deliberate distractor — don't take the bait.
Common mistake
Wrong: Chronic inflammation always develops as a sequel to unresolved acute inflammation.
Right: Chronic inflammation can arise de novo without a preceding acute phase, as seen in autoimmune diseases, persistent infections with low-virulence organisms, and prolonged exposure to toxic agents.
The acute → chronic progression is one pathway, but it's not the only one. Autoimmune diseases like rheumatoid arthritis and Hashimoto's thyroiditis begin with lymphocyte and macrophage infiltration from day one, with no prior classic acute phase. Similarly, Mycobacterium tuberculosis and fungi provoke granulomatous chronic inflammation without a dominant initial neutrophilic response. The key mental model: chronic inflammation is defined by its cellular composition and duration, not by a required history of unresolved acute inflammation.
Common mistake
Gap: Misses fibrosis as a major long-term consequence of chronic inflammation mediated by TGF-beta
Chronic inflammation frequently leads to fibrosis through TGF-beta-driven myofibroblast activation and collagen deposition, causing permanent structural organ damage.
Fibrosis is not just passive scarring — it's an active process driven by TGF-beta, which is secreted primarily by macrophages and damaged epithelial cells. TGF-beta activates fibroblasts to become myofibroblasts, which deposit excess collagen type I and III into the extracellular matrix. This replaces functional parenchyma with non-functional scar tissue, causing permanent organ dysfunction — cirrhosis in the liver, pulmonary fibrosis in the lung, and constrictive pericarditis in the heart are all examples. USMLE Step 1 expects you to connect chronic inflammation → TGF-beta → myofibroblast → fibrosis as a mechanistic chain, not just say 'it scars.'
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify the dominant cell types in chronic inflammation — macrophages, lymphocytes, and plasma cells — and distinguish them from the neutrophil-dominated cellular infiltrate of acute inflammation.
  2. Recognize the categories of triggers that cause chronic inflammation, including persistent infections with low-virulence organisms, autoimmune and immune-mediated diseases, and prolonged exposure to toxic or foreign material — any of which can initiate chronic inflammation without a preceding acute phase.
  3. Predict the long-term tissue consequences of chronic inflammation, especially fibrosis driven by TGF-beta-mediated myofibroblast activation and collagen deposition, and understand how this leads to permanent structural organ damage.

Can you avoid these mistakes?

A biopsy from a patient with a 2-year history of Crohn's disease shows a dense mononuclear infiltrate with large cells containing abundant pink cytoplasm, smaller cells with condensed nuclear chromatin, and cells with eccentric nuclei and a 'clock-face' chromatin pattern. What are these three cell types, and what does their presence tell you about the type of inflammation?
A 35-year-old woman is diagnosed with Hashimoto's thyroiditis. Her pathology shows lymphocytic infiltration and germinal center formation from the time of initial biopsy. A student claims this is chronic inflammation that must have followed an earlier acute phase. Why is this student wrong, and what does this case illustrate about the triggers of chronic inflammation?
A patient with longstanding silicosis develops progressive dyspnea and restrictive physiology on pulmonary function testing. What cytokine is most responsible for the structural lung changes, what cell type produces it, and what is the effector cell responsible for laying down collagen?
You are given two biopsies: one shows vascular dilation, edema, and a cellular infiltrate with multilobed nuclei and granular cytoplasm; the other shows a dense infiltrate of mononuclear cells with tissue destruction and early scar formation. Which is acute and which is chronic, and what is the single most important cellular feature distinguishing them?

Related topics

Acute Inflammation (Cardinal Signs, Vascular Changes, Leukocyte Recruitment) Reversible vs Irreversible Cell Injury Types of Necrosis Apoptosis (Intrinsic and Extrinsic Pathways) Cell Adaptations (Atrophy, Hypertrophy, Hyperplasia, Metaplasia, Dysplasia)

See how your Anki deck covers this topic.

Upload your deck for a free audit →